Growth Hormone Releasing Hormone: Behavioral Evidence for Direct Central Actions

  • Franco J. Vaccarino
  • Sidney H. Kennedy
Part of the Serono Symposia USA Norwell, Massachusetts book series (SERONOSYMP)


Growth hormone releasing hormone (GHRH) peptides have been isolated and characterized from human pancreatic tumor (1, 2) and from hypothalami of several species including rat and human (3–6). GHRH peptides have strong homology with peptides of the glucagon, vasoactive intestinal polypeptide, and PHI-27 family. Many of the GHRH neurons have their cell bodies in the arcuate nucleus of the hypothalamus with fibers extending into the median eminence (7–9). GHRH-containing terminals in the median eminence are located proximal to capillaries that drain into the hypophysial portal blood system. It is through this system that GHRH stimulates the release of growth hormone from cells in the anterior pituitary gland (10). The characterization and synthesis of GHRH represents a significant development and has opened important new avenues for the direct study of GHRH function.


Growth Hormone Anorexia Nervosa Median Eminence Growth Hormone Response Increase Food Intake 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Guillemin R, Brazeau P, Bohlen P, Esch F, Ling N, Wehrenberg WB. Growth hormone-releasing factor from a human pancreatic tumour that caused acromegaly. Science 1982;218:585–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Rivier J, Speiss J, Thorner M, Vale W. Characterization of a growth hormone- releasing factor from a human pancreatic islet tumour. Nature 1982;300:276–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Bohlen P, Esch F, Brazeau P, Ling N, Guillemin R. Isolation and characterization of the porcine hypothalamic growth hormone-releasing factor. Biochem Biophys Res Commun 1983;117:726–34.CrossRefGoogle Scholar
  4. 4.
    Bohlen P, Esch F, Brazeau P, Ling N, Guillemin R. Isolation and characterization of the bovine hypothalamic growth hormone-releasing factor. Biochem Biophys Res Commun 1983;117:772–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Ling N, Esch F, Bohlen P, Brazeau P, Wehrenberg WB, Guillemin R. Isolation, primary structure and synthesis of human hypothalamic somatocrinin: growth hormone releasing factor. Proc Natl Acad Sci USA 1984;81:4302–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Spiess J, Rivier J, Vale W. Characterization of rat hypothalamic growth hor-mone-releasing factor. Nature 1983;303:532–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Sawchenko PE, Swanson LW, Rivier J, Vale WW. The distribution of growth- hormone-releasing factor (GRF) immunoreactivity in the central nervous system of the rat: an immunohistochemical study using antisera directed against rat hypothalamic GRF. J Comp Neurol 1985;327:100–15.CrossRefGoogle Scholar
  8. 8.
    Merchenthaler I, Thomas CR, Arimura A. Immunohistochemical localization of growth hormone-releasing factor (GHRF)-containing structures in the rat brain using antirat GHRF serum. Peptides 1984;5:1071–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Bloch B, Brazeau P, Ling N, Bohlen P, Esch F, Wehrenberg WB, Benoit R, Bloom F. Immunohistochemical detection of growth hormone-releasing factor in the brain. Nature 1983;263:251–7.Google Scholar
  10. 10.
    Plotsky PM, Vale W. Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science 1985;230:461–3.PubMedCrossRefGoogle Scholar
  11. 11.
    Twery MJ, Moss RL. Sensitivity of rat forebrain neurons to growth hormone- releasing hormone. Peptides 1985;6:609–13.PubMedCrossRefGoogle Scholar
  12. 12.
    Scharrer B. Neurosecretion: beginnings and new directions in neuropeptide research. Annu Rev Neurosci 1987;10:1–17.PubMedCrossRefGoogle Scholar
  13. 13.
    Vaccarino FJ, Bloom FE, Rivier J, Vale W, Koob GF. Stimulation of food intake in rats by centrally administered hypothalamic growth hormone- releasing factor. Nature 1985;314:167–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Vaccarino FJ, Feifel D, Rivier J, Vale W, Koob GF. Centrally administered growth hormone-releasing factor stimulates food intake in free-feeding rats. Peptides 1988;9(suppl l):35–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Feifel D, Vaccarino FJ. Feeding effects of growth hormone-releasing factor in rats are photoperiod sensitive. Behav Neurosci 1989;103:824–30.PubMedCrossRefGoogle Scholar
  16. 16.
    Vaccarino FJ, Buckenham K. Naloxone blockade of growth hormone-releasing factor-induced feeding. Regul Pept 1987;18:165–71.PubMedCrossRefGoogle Scholar
  17. 17.
    Riviere P, Bueno L. Influence of regimen and insulinemia on orexigenic effects of GRF (1-44) in sheep. Physiol Behav 1987;39:347–450.PubMedCrossRefGoogle Scholar
  18. 18.
    Imaki T, Shibasaki T, Hotta M, Masuda A, Demure H, Shizume K, Ling N. The satiety effect of growth hormone-releasing factor in rats. Brain Res 1985;340:168–88.CrossRefGoogle Scholar
  19. 19.
    Wehrenberg WB, Ehlers CL. Effects of growth hormone-releasing factor in the brain. Science 1986;232:1271–3.PubMedCrossRefGoogle Scholar
  20. 20.
    Rosenwasser AM, Boulous Z, Terman M. Circadian organization of food intake and meal patterns in the rat. Physiol Behav 1979;27:33–9.CrossRefGoogle Scholar
  21. 21.
    Margules DL. Hypothalamic norepinephrine: circadian rhythms and the control of feeding behavior. Science 1972;178:640–2.PubMedCrossRefGoogle Scholar
  22. 22.
    Feifel D, Vaccarino FJ. Growth hormone-regulatory peptides (GHRH and somatostatin) and feeding: a model for the integration of central and peripheral function. Neurosci Biobehav Rev 1994;18:421–33.PubMedCrossRefGoogle Scholar
  23. 23.
    Vaccarino FJ, Hayward M. Microinjections of growth hormone-releasing factor into the medial preoptic area/suprachiasmatic nucleus region of the hypothalmus stimulate food intake in rats. Regul Pept 1988;21:21–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Leibowitz SF. Adrenergic stimulation of the paraventricular nucleus and its effects on ingestive behavior as a function of drug dose and time of injection in the light-dark cycle. Brain Res Bull 1977;3:357–63.CrossRefGoogle Scholar
  25. 25.
    Tanaka Y, Egawa M, Inoue S, Takamura Y. Effect of hypothalamic administration of growth hormone-releasing factor (GRF) on feeding behavior in rats. Brain Res 1991;558:273–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Rusak B, Zucker I. Neural regulation of circadian rhythms. Physiol Rev 1979;59:449–526.PubMedGoogle Scholar
  27. 27.
    Vaccarino FJ, Sovran P, Baird JP, Ralph M. Growth hormone-releasing hormone mediates feeding-specific feedback to the suprachiasmatic circadian clock. Peptides 1995;16:595–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Danguir J. Food intake in rats increased by intracerebroventricular infusion of the somatostatin analogue SMS 201-995 and is decreased by somatostatin antiserum. Peptides 1987;9:211–3.CrossRefGoogle Scholar
  29. 29.
    Rezek MT, Havlicek V, Hughes R, Friesen H. Central site of action of somatostatin (SRIF): role of hippocampus. Neuropsychology 1976;15:499–504.Google Scholar
  30. 30.
    Lin MT, Chen JJ, Ho LT. Hypothalamic involvement in the hyperglycemia and satiety actions of somatostatin in rats. Neuroendocrinology 1987;45:62–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Shibasaki T, Kim YS, Yamauchi N, Masuda A, Imaki T, Hotta M, Deura H, Wakabayshi I, Ling N, Shizume K. Antagonistic effect of somatostatin on corticotropin-releasing factor induced anorexia. Life Sci 1988;42:329–34.PubMedCrossRefGoogle Scholar
  32. 32.
    Vijayan E, McCann SM. Suppression of feeding and drinking activity in rats following intraventricular injection of thyrotropin releasing hormone (TRH). Endocrinology 1977;100:1727–30.PubMedCrossRefGoogle Scholar
  33. 33.
    Aponte G, Leung P, Gross D, Yamada T. Effects of somatostatin on food intake in rats. Life Sci 1984;35:741–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Levine AS, Morley JE. Peripherally administered somatostatin reduced feeding by a vagally mediated mechanism. Pharmacol Biochem Behav 1982;16:897–902.PubMedCrossRefGoogle Scholar
  35. 35.
    Lotter EC, Krinksy R, McKay JM, Treener CM, Porte D, Woods SC. Somatostatin decreases the food intake of rats and baboons. J Comp Physiol Psychol 1981;95:278–87.PubMedCrossRefGoogle Scholar
  36. 36.
    Feifel D, Vaccarino FJ. Central somatostain: a reexamination of its effects on feeding. Brain Res 1990;535:189–94.PubMedCrossRefGoogle Scholar
  37. 37.
    Feifel D, Vaccarino FJ, Rivier J, Vale W. Evidence for a common neural mechanism mediating GRF-induced and somatostatin-induced feeding. Neuroendocrinology 1993;57(2):299–305.PubMedCrossRefGoogle Scholar
  38. 38.
    Dickson PR, Vaccarino FJ. GRF-induced feeding: evidence for protein selectivity and opiate involvement. Peptides 1994;15:1343–52.PubMedCrossRefGoogle Scholar
  39. 39.
    Dickson PR, Vaccarino FJ. Characterization of feeding behavior induced by central injection of GRF. Am J Physiol 1990;259:r651–7.PubMedGoogle Scholar
  40. 40.
    Feifel D, Vaccarino FJ. Central injections of growth hormone-releasing factor increase operant responding for food reward. Prog Neuropsychopharmacol Biol Psychiatry 1990;14:813–20.PubMedCrossRefGoogle Scholar
  41. 41.
    Leibowitz SF. Brain monoamines and peptides: role in the control of eating behavior. Fed Proc 1986;45:1396–403.PubMedGoogle Scholar
  42. 42.
    Vaccarino FJ, Feifel D, Rivier J, Vale W. Antagonism of central growth hormone-releasing factor activity selectively attenuates dark-onset feeding in rats. J Neurosci 1991;ll(12):3924–7.Google Scholar
  43. 43.
    Dickson PR, Feifel D, Vaccarino FJ. Blockade of endogenous GRF at dark onset selectively suppresses protein intake. Peptides 1995;16:7–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Brambilla F, Ferrari E, Cavagnini F, et al. 2-Adrenoceptor sensitivity in anorexia nervosa: GH response to clonidine or GHRH stimulation. Biol Psychiatry 1989;25:256–64.PubMedCrossRefGoogle Scholar
  45. 45.
    Rolla M, Andreoni D, Belliti D, Ferdeghini M, Ferrannini E. Failure of glucose infusion to suppress the exaggerated GH response to GHRH in patients with anorexia nervosa. Biol Psychiatry 1990;27:215–22.PubMedCrossRefGoogle Scholar
  46. 46.
    Tamai H, Komai G, Matsubayashi S, et al. Effects of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(l-44)- induced GH secretion in anorexia nervosa. J Clin Endocrinol Metab 1990;70(3):738–41.PubMedCrossRefGoogle Scholar
  47. 47.
    Vaccarino FJ, Kennedy SH, Ralevski E, Black R. The effects of growth hormone-releasing factor on food consumption in anorexia nervosa patients and normals. Biol Psychiatry 1994;35:446–51.PubMedCrossRefGoogle Scholar
  48. 48.
    Kastin AA, Banks WA, Zadina JE. A decade of changing perceptions about neuropeptides. Ann NY Acad Sci 1990;579:1–7.PubMedCrossRefGoogle Scholar
  49. 49.
    Woods SC, Decke E, Vasselli JR. Metabolic hormones and regulation of body weight. Psychol Rev 1974;81:26–43.PubMedCrossRefGoogle Scholar
  50. 50.
    Even P, Danguir J, Nicolaidis S, Rougeiot C, Dray F. Pulsatile secretion of growth hormone and insulin in relation to feeding in rats. Am J Physiol 1987;253:R772–8.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1996

Authors and Affiliations

  • Franco J. Vaccarino
  • Sidney H. Kennedy

There are no affiliations available

Personalised recommendations